These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 17047036)

  • 21. Mechanisms Underlying Tumor Suppressive Properties of Melatonin.
    Bondy SC; Campbell A
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30060531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The convergent development of molecular-targeted drugs for cancer treatment and prevention.
    Lippman SM; Heymach JV
    Clin Cancer Res; 2007 Jul; 13(14):4035-41. PubMed ID: 17634526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The validity of melatonin as an oncostatic agent.
    Panzer A; Viljoen M
    J Pineal Res; 1997 May; 22(4):184-202. PubMed ID: 9247204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemotherapy with immunomodulating pineal hormones other than melatonin: 5-methoxytryptamine as a new oncostatic pineal agent.
    Lissoni P
    Pathol Biol (Paris); 2007; 55(3-4):198-200. PubMed ID: 17451889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using chemopreventive agents to enhance the efficacy of cancer therapy.
    Sarkar FH; Li Y
    Cancer Res; 2006 Apr; 66(7):3347-50. PubMed ID: 16585150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melatonin: from basic research to cancer treatment clinics.
    Vijayalaxmi ; Thomas CR; Reiter RJ; Herman TS
    J Clin Oncol; 2002 May; 20(10):2575-601. PubMed ID: 12011138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fungal metabolites modulating NF-kappaB activity: an approach to cancer therapy and chemoprevention (review).
    Petrova RD; Reznick AZ; Wasser SP; Denchev CM; Nevo E; Mahajna J
    Oncol Rep; 2008 Feb; 19(2):299-308. PubMed ID: 18202775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemopreventive effects of natural dietary compounds on cancer development.
    Pan MH; Ho CT
    Chem Soc Rev; 2008 Nov; 37(11):2558-74. PubMed ID: 18949126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current status and future prospects for satraplatin, an oral platinum analogue.
    Choy H; Park C; Yao M
    Clin Cancer Res; 2008 Mar; 14(6):1633-8. PubMed ID: 18347164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The convergence of cancer prevention and therapy in early-phase clinical drug development.
    Abbruzzese JL; Lippman SM
    Cancer Cell; 2004 Oct; 6(4):321-6. PubMed ID: 15488755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo.
    Adhami VM; Malik A; Zaman N; Sarfaraz S; Siddiqui IA; Syed DN; Afaq F; Pasha FS; Saleem M; Mukhtar H
    Clin Cancer Res; 2007 Mar; 13(5):1611-9. PubMed ID: 17332308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pineal hormone melatonin in complex pharmacotherapy of brain and somatic disorders].
    Arushanian EB
    Eksp Klin Farmakol; 2011; 74(9):39-45. PubMed ID: 22164447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lycopene in cancer prevention and treatment.
    Seren S; Lieberman R; Bayraktar UD; Heath E; Sahin K; Andic F; Kucuk O
    Am J Ther; 2008; 15(1):66-81. PubMed ID: 18223356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melatonin, experimental basis for a possible application in breast cancer prevention and treatment.
    Cos S; Sánchez-Barceló EJ
    Histol Histopathol; 2000 Apr; 15(2):637-47. PubMed ID: 10809385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melatonin May Increase Anticancer Potential of Pleiotropic Drugs.
    Bojková B; Kubatka P; Qaradakhi T; Zulli A; Kajo K
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomarker and animal models for assessment of retinoid efficacy in cancer chemoprevention.
    Niles RM
    Acta Pharmacol Sin; 2007 Sep; 28(9):1383-91. PubMed ID: 17723172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melatonin as antioxidant, geroprotector and anticarcinogen.
    Anisimov VN; Popovich IG; Zabezhinski MA; Anisimov SV; Vesnushkin GM; Vinogradova IA
    Biochim Biophys Acta; 2006; 1757(5-6):573-89. PubMed ID: 16678784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review.
    Bizzarri M; Proietti S; Cucina A; Reiter RJ
    Expert Opin Ther Targets; 2013 Dec; 17(12):1483-96. PubMed ID: 24032643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting multiple signal pathways by chemopreventive agents for cancer prevention and therapy.
    Sarkar FH; Li YW
    Acta Pharmacol Sin; 2007 Sep; 28(9):1305-15. PubMed ID: 17723164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.